Single- and Multiple-Dose Study to Determine the Safety, Tolerability, Pharmacokinetics, and Food Effect of Oral MRX-I Versus Linezolid in Healthy Adult Subjects

发布时间：2017-05-13 / 浏览次数：334 次

上一篇： Metabolism of MRX-I, a novel antibacterial oxazolidinone, in humans: the oxidative ring opening of 2,3-dihydropyridin-4-one catalyzed by non-P450 enzymes

下一篇： In Vitro and In Vivo Activities of Contezolid (MRX-I) against Mycobacterium tuberculosis

返回列表